Recruiting
Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed Diabetes
The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.
ClinicalTrials.gov IDNCT03827382
PhaseNA
Enrollment62
SponsorUniversity Hospital, Basel, Switzerland
Age18 Years
SexALL
Conditions studied
Life Style
About this study
The aim of the study is to test the efficacy, feasibility, and safety of a bicycle exercise followed by an intensive lifestyle intervention for 3 months in patients with recent onset and medically untreated type 2 diabetes.
Interventions
- Behavioral: Lifestyle Intervention — Physical activity program: 3-5 aerobic training sessions (15-40 minutes each) per week, combined with 2 resistance training per week as well as motivational coaching via telephone Nutritional counseling
Primary outcomes
- metabolic control (3 months)
Eligibility information
Inclusion Criteria:
* Informed consent as documented by signature
* Type 2 diabetes diagnosed within the last two years according to the American Diabetes Association (ADA) criteria
* Age ≥ 18 years
* HbA1c ≥ 7.5 %
Exclusion Criteria:
* Clinically instable patient as defined by the physicians on duty including signs of new cardiac ischemia in the ECG, systolic blood pressure ≥ 200 mmHg, fever ≥ 38.5 °C, symptoms of SIRS or reduced vigilance.
* Anti-diabetic medication for ≥ 24 hours
* Inability to perform a bicycle exercise during 30 minutes
* Previous lifestyle-intervention by an endocrinologist
* Engagement in physical activity more than five times per week
* Enrollment in other interventional study
Study locations
- University of Basel, Basel, Canton of Basel-City 4031 Switzerland
- Cantonal Hospital Olten, Olten, Canton of Solothurn 4600 Switzerland
- Hopital du Jura, Delémont, 2800 Switzerland
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.